World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
51
Citations
8865
World Ranking
5555
National Ranking
32

Overview

Eduard Auff is affiliated with the Medical University of Vienna in Austria. Their research is focused primarily within the field of Medicine, with notable contributions to several subfields including Neurology, Epidemiology, Cardiology and Cardiovascular Medicine, Internal Medicine, and Pathology and Forensic Medicine.

Their scholarly work spans a range of clinical and neurological topics. Major themes in their research include:

  • Acute Ischemic Stroke Management
  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Botulinum Toxin and Related Neurological Disorders
  • Trigeminal Neuralgia and Treatments
  • Facial Nerve Paralysis Treatment and Research

Eduard Auff has published articles in peer-reviewed journals such as the Journal of Neurology and Archives of Physical Medicine and Rehabilitation. Some of the key recent papers are:

  • Time trends in stroke severity in the years 2005 to 2020: results from the Austrian Stroke Unit Registry, 2022, Journal of Neurology
  • Cognitive Performance After Facial Botulinum Toxin Treatment in a Cohort of Neurologic Patients: An Exploratory Study, 2021, Archives of Physical Medicine and Rehabilitation

The researcher collaborates frequently with experts including Thomas Gattringer, Stefan Kiechl, Alexandra Bernegger, Dominika Mikšová, and Alexandra Posekany. Collaboration counts indicate multiple shared publications, particularly with Gattringer and Kiechl.

Eduard Auff's work integrates clinical neurology with epidemiological approaches to address both acute and chronic neurological conditions. Their contributions to stroke management and neurotoxin-related neurological dysfunctions highlight interdisciplinary application across neurology and internal medicine.

Best Publications

  • A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

    Alexander Zimprich;Anna Benet-Pagès;Walter Struhal;Elisabeth Graf

  • Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.

    Assunta Dal-Bianco;Günther Grabner;Claudia Kronnerwetter;Michael Weber

  • Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms

    P. Schnider;M. Binder;E. Auff;H. Kittler

  • Variant in the sequence of the LINGO1 gene confers risk of essential tremor.

    Hreinn Stefansson;Stacy Steinberg;Hjorvar Petursson;Omar Gustafsson

  • Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome

    I. Eisensehr;T. C. Wetter;R. Linke;S. Noachtar

  • Long-term antidyskinetic efficacy of amantadine in Parkinson's disease

    Elisabeth Wolf;Klaus Seppi;Regina Katzenschlager;Guenter Hochschorner

  • Neurological rehabilitation of severely disabled cardiac arrest survivors. Part II. Life situation of patients and families after treatment

    Gisela Pußwald;Elisabeth Fertl;Margit Faltl;Eduard Auff

  • Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa

    E. Fertl;E. Auff;A. Doppelbauer;F. Waldhauser

  • A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.

    B. Voller;T. Sycha;B. Gustorff;L. Schmetterer

  • Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study

    T. Sycha;M. Graninger;E. Auff;P. Schnider

  • Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene

    D. Haubenberger;R. E. Bittner;S. Rauch-Shorny;F. Zimprich

  • Neuropsychological, MRI and EEG findings after very mild traumatic brain injury.

    B Voller;T Benke;K Benedetto;P Schnider

  • Sleep disorders and depression in patients with Parkinson's disease.

    S. Happe;B. Schrödl;M. Faltl;C. Müller

  • Awareness of memory deficits in subjective cognitive decline, mild cognitive impairment, Alzheimer's disease and Parkinson's disease.

    Johann Lehrner;Sandra Kogler;Claus Lamm;Doris Moser

  • Relation between depression and anxiety in dystonic patients: implications for clinical management.

    E. Moraru;P. Schnider;A. Wimmer;T. Wenzel

  • Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.

    P. Schnider;E. Moraru;H. Kittler;M. Binder

  • Impairment of motor planning in patients with Parkinson's disease: evidence from ideomotor apraxia testing.

    G Goldenberg;A Wimmer;E Auff;G Schnaberth

  • Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study.

    J. Wissel;P. Kanovsky;E. Ruzicka;M. Bares

  • Circadian secretion pattern of melatonin in Parkinson's disease.

    E Fertl;E Auff;A Doppelbauer;F Waldhauser

  • Health-Related Quality of Life in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment and its Relation to Activities of Daily Living.

    Gisela Pusswald;Elisa Tropper;Ilse Kryspin-Exner;Doris Moser

  • Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson's disease

    Dietrich Haubenberger;Eva Reinthaler;Jakob C. Mueller;Walter Pirker

  • Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy

    T. Berger;R. Malayer;A. Doppelbauer;G. Krajnik

Frequent Co-Authors

Georg S. Kranz
Georg S. Kranz Hong Kong Polytechnic University
Werner Poewe
Werner Poewe Innsbruck Medical University
Josef Zeitlhofer
Josef Zeitlhofer Medical University of Vienna
Martin Kronbichler
Martin Kronbichler University of Salzburg
Peter Lichtner
Peter Lichtner Technical University of Munich
Claus Lamm
Claus Lamm University of Vienna
Ilse Kryspin-Exner
Ilse Kryspin-Exner University of Vienna
Kari Stefansson
Kari Stefansson deCODE Genetics (Iceland)
Unnur Thorsteinsdottir
Unnur Thorsteinsdottir deCODE Genetics (Iceland)
Thomas Meitinger
Thomas Meitinger Technical University of Munich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying neuroscience opens doors to a wide range of online degrees and career pathways—in both clinical and research-focused roles. Those interested in the health and caring professions often pursue online MSW programs, which offer a fast, flexible way to obtain a Master of Social Work and prepare for roles supporting mental health in diverse communities.

Psychology remains a top choice for students looking to understand the mind and behavior. Many opt for a fastest online psychology degree to jumpstart their careers in counseling, research, or education. Similarly, for those who aim to become licensed counselors, choosing a CACREP online masters in counseling ensures a curriculum that meets industry standards and job readiness.

If you're considering entry-level roles or a stepping stone to graduate study, a counseling bachelor's degree online provides affordable and flexible options. Each of these pathways can complement your neuroscience studies and expand your career opportunities in healthcare, education, and research.

Best Scientists Citing Eduard Auff

Trending Scientists